Alpha Wave Global, LP Lava Therapeutics Nv Transaction History
Alpha Wave Global, LP
- $191 Million
- Q2 2024
A detailed history of Alpha Wave Global, LP transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Alpha Wave Global, LP holds 87,397 shares of LVTX stock, worth $167,802. This represents 0.08% of its overall portfolio holdings.
Number of Shares
87,397
Previous 107,906
19.01%
Holding current value
$167,802
Previous $359,000
56.27%
% of portfolio
0.08%
Previous 0.2%
Shares
8 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.8MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.98 Million0.24% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.48 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$705,7570.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$215,8820.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$196,8000.04% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $49.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...